OptTEST Press Release: Optimising Testing and Linkage to Care for HIV Across Europe
“Testing is the entry step to saving lives and must be fully accessible”
The OptTEST (Optimising Testing and Linkage to Care) project contributed to the global and European discussion about innovative and effective HIV testing strategies and linkage to care at the AIDS2016 Conference in Durban, South Africa. Scale up of testing and access to life-saving medication alongside the elimination of stigma and discrimination towards certain key populations are essential and cannot be delayed if we want to achieve the UNAIDS 90-90-90 target, and stop the HIV epidemic in Europe1.
Read more »
EATG at the AIDS 2016 Conference in Durban
EATG is not only represented by a legion of capable members, but also hosts the European Networking Zone together with AIDS Action Europe and ECUO. A delegation of almost 30 members.
The presence of a large and strong delegation of the communities of people living with and affected by HIV in Europe and Central Asia is even more important as both the IAS and the AIDS Conferences will come to Europe (2017 - Paris, 2018 - Amsterdam). We will start building bridges to our communities across the globe to explore the common issues, tasks and missions that await us in the effective response to the HIV/AIDS epidemic on the community's side.
Read more »
Community Consensus Statement on Access to HIV Treatment and Its Use for Prevention
The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap.
On the eve of the 2016 International AIDS Conference, eight global HIV advocacy groups have released a consensus statement setting out basic principles for provision of antiretroviral treatment (ART) and pre-exposure prophylaxis (PrEP). Please read it and sign your support at www.hivt4p.org.
Read more »
2nd Paris NASH Symposium: 2016 Edition
On June 30 - July 1, 2016, the 2nd Paris NASH Symposium French-US Meetings 2016 Edition was held in Paris, France. The symposium was organized by Arun Sanyal of the Virginia Commonwealth University School of Medicine, and Lawrence Serfaty of the Hopital Saint-Antoine, APHP, Inserm, Universite Pierre & Marie Curie.
Read more »
Flagstaff International Relief Effort (FIRE): Hepatitis Updates
World Health (WHO) Organization Award
In April 2016, the Flagstaff International Relief Effort (FIRE) was honored to be selected as one of five organizations to be recognized by the WHO (World Health Organization) and EASL (European Association for Study of the Liver) for innovative hepatitis screening programs.
FIRE's project will be included in the first edition of WHO's "Hepatitis Screening Guidelines." Meredith Potts, FIRE's Executive Director, also presented this project at EASL's annual International Liver Congress in Barcelona, Spain.
Read more »
Harvard's Notorious Pathogens Course - Open for Registration
The Harvard T.H. Chan School of Public Health announces a new executive education program entitled "Notorious Pathogens of Infectious Diseases: Detection, Treatment, Control and Eradication."
The global world makes infectious diseases a reality —one all have to contend with— and, because of interconnectedness, every country, health system, hospital, and overseas employer must be prepared for the next pandemic. Yet, many are not. Notorious Pathogens of Infectious Diseases has been designed to give participants the most current information needed to formulate an action plan in preparation for the world’s next outbreak.
Read more »
Consultation on Global Trends of HIV Drug Resistance: Sponsored by National Institute of Allergy and Infectious Diseases
On May 3-4, 2016, the National Institute of Allergy and Infectious Diseases (NIAID) sponsored the Consultation on Global Trends of HIV Drug Resistance in Rockville, MD. The goals of the conference were to identify research gaps for HIV Drug Resistance (HIVDR) in low and middle income countries (LMIC) and to develop collaborations between key members of academia, government, industry, and non-profit organizations to address these gaps through an actionable plan.
Read more »
The National Academies Press: Eliminating the Public Health Problem of Hepatitis B and C in the United States - Phase One Report
Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world’s hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide.
Read more »
WHA: HIV and Hepatitis Co-Infections
Originally posted by International AIDS Society (IAS) here.
IAS blog entry by Sébastien Morin, International AIDS Society, Eliot Ross Albers, Independent (formerly at the International Network of People Who Use Drugs), and Jürgen Rockstroh, University of Bonn
HOW TO MEET THE FIRST-EVER GLOBAL HEPATITIS TARGETS
The first-ever global targets on viral hepatitis were adopted at the 69th World Health Assembly last week. These targets include:
- Reduce new cases of chronic hepatitis by 30% (2020) and 90% (2030) (baseline 2015). Reduce from 6-10 million new cases in 2015 to < 1 million in 2030
- Reduce hepatitis B (HBV) and hepatitis C (HCV) mortality by 10% (2020) and 90% (2030) (baseline 2015). Reduce from 1.4 million deaths in 2015 to < 500,000 deaths in 2030
Read more »
Originally posted by International AIDS Society (IAS) here.
ADOPTED GLOBAL HEALTH SECTOR STRATEGIES FOR HIV, VIRAL HEPATITIS AND SEXUALLY TRANSMITTED INFECTIONS
Last week at the 69th World Health Assembly (WHA), the Global Health Sector Strategies for HIV, viral hepatitis and sexually transmitted infections (STIs), 2016-2021 were formally adopted on 28 May.
This is an important milestone as the three strategies are fully aligned with supporting the attainment of the Sustainable Development Goals (SDGs), which include targets to end the HIV epidemic as a public health threat by 2030 and to combat viral hepatitis and other communicable diseases, including STIs. The successful adoption of the three Global Health Sector Strategies for HIV, viral hepatitis and STIs provides an avenue for focused priority setting across the health response. These targets represent the following key benchmarks:
Read more »
|
|